2020 American Transplant Congress » Kidney Immunosuppression: Induction Therapy

Date: Saturday, May 30, 2020

Time: 3:15pm-4:45pm

Location: Virtual

Session Type: Oral Abstract Session

Meeting: 2020 American Transplant Congress

3:15pm-3:27pm: Thymoglobulin (ATG) Induction vs. Campath vs. Simulect in DCD Kidneys in UK; Induction Regimes Play a Role after All

A. Asderakis¹, T. Sabbah¹, J. Watkins², L. Szabó¹, D. Elker¹, A. M. Ilham¹, E. Ablorsu¹, M. Stephens¹, U. Khalid¹, R. Chavez¹

3:27pm-3:39pm: Evaluation of Infectious and Malignant Complications in Elderly Renal Transplant Recipients Receiving Alemtuzumab Compared to Basiliximab

K. Lang¹, J. Shulte¹, K. Cunningham¹, C. D'Agostino¹, M. Kapugi¹, C. Kane¹, A. Novak¹, J. Leventhal²

3:39pm-3:51pm: Belatacept-Based Regimens: Induction and Recipient Gender Influence Outcomes

N. Wilson¹, A. R. Shields², A. Wiseman³, A. L. Christianson¹, S. Tremblay¹, D. Kaufman⁴, J. P. Leone⁵, A. J. Matas⁶, P. West-Thielke⁷, R. R. Alloway¹, E. S. Woodle¹

3:51pm-4:03pm: Incident Malignancies among Post Kidney-Transplant Patients by Type of Induction Immunosuppression and by Age

L. Wang, J. Motter, S. Bae, D. Segev, M. McAdams DeMarco

4:03pm-4:15pm: Single-Dose Anti-Thymocyte Globulin is Non-Inferior to Divided-Dose for Induction Therapy in Kidney and Pancreas Transplantation

A. I. Ingemi¹, O. F. Bangash¹, S. McCoy¹, L. Hulse², J. Colonna¹, H. Sadr¹, S. Sutton¹, M. Coleman¹, T. Wilson¹, T. R. McCune¹

4:15pm-4:27pm: The FcγRIIIa-158 VV Genotype Increased the Risk of Post-Transplant Lymphoproliferative Disorder in T-Cell Depleted Kidney Transplant Recipients

P. Gatault¹, L. Lajoie¹, J. Stojanova², P. Marquet², G. Thibault¹

4:27pm-4:39pm: Anti-Thymocyte Globulin versus Interleukin-2 Receptor Antagonist and Deceased-Donor Kidney Transplant Outcomes among Older Recipients

J. Ahn¹, S. Bae¹, K. Lentine², M. Schnitzler², G. Hess³, D. Segev¹, M. McAdams-DeMarco¹

« View all sessions from the 2020 American Transplant Congress